AKLI

Analyst Sentiment

Wall St. Consensus
Buy
4 analysts·Low coverage
63
Score
2 Buy (50%)2 Hold (50%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
250%
Hold
250%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
+361.8%
Consensus
$3.25
+650.4%
Bull
$4.50
+939.0%
12-Month Target Range4 analysts
$2.00$3.25$4.50
Current $0.43Consensus
Current Price
$0.43
Upside to Consensus
$2.82

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+54.62%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027E
Revenue Avg$9M$13M
Low$9M$13M
High$9M$13M
EBITDA Avg$-9M$-13M
Low$-9M$-13M
High$-9M$-13M
EBIT Avg$-9M$-13M
Low$-9M$-13M
High$-9M$-13M
Net Income Avg$-37M$-39M
Low$-37M$-39M
High$-37M$-39M
EPS Avg$-0.47$-0.50
Low$-0.47$-0.50
High$-0.47$-0.50
Analysts (Rev / EPS)1 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026
Revenue Avg$2M$2M
Low$2M$2M
High$2M$2M
EBITDA Avg$-2M$-2M
Low$-2M$-2M
High$-2M$-2M
EBIT Avg$-2M$-2M
Low$-2M$-2M
High$-2M$-2M
Net Income Avg$-10M$-10M
Low$-10M$-10M
High$-10M$-10M
EPS Avg$-0.13$-0.13
Low$-0.13$-0.13
High$-0.13$-0.13
Analysts (Rev / EPS)1 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Dec 28, 2022Morgan Stanley
Morgan Stanley Initiates Coverage On Akili with Equal-Weight Rating, Announces Price Target of $2
Target:$2.00
+94.8%from $1.03
Nov 15, 2022Credit Suisse
Credit Suisse Maintains Outperform on Akili, Raises Price Target to $4.5
Target:$4.50
+155.7%from $1.76
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.